Literature DB >> 12588846

Dp1 is required for extra-embryonic development.

Matthew J Kohn1, Roderick T Bronson, Ed Harlow, Nicholas J Dyson, Lili Yamasaki.   

Abstract

Release of E2F1/DP1 heterodimers from repression mediated by the retinoblastoma tumor suppressor (pRB) triggers cell cycle entry into S phase, suggesting that E2F1 and DP1 proteins must act in unison, either to facilitate or to suppress cell-cycle progression. In stark contrast to the milder phenotypes that result from inactivation of E2Fs, we report that loss of Dp1 leads to death in utero because of the failure of extra-embryonic development. Loss of Dp1 compromises the trophectoderm-derived tissues - specifically, the expansion of the ectoplacental cone and chorion, and endoreduplication in trophoblast giant cells. Inactivation of p53 is unable to rescue the Dp1-deficient embryonic lethality. Thus, DP1 is absolutely required for extra-embryonic development and consequently embryonic survival, consistent with E2F/DP1 normally acting to promote growth in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12588846     DOI: 10.1242/dev.00355

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  26 in total

1.  Rb function in extraembryonic lineages suppresses apoptosis in the CNS of Rb-deficient mice.

Authors:  Alain de Bruin; Lizhao Wu; Harold I Saavedra; Pamela Wilson; Ying Yang; Thomas J Rosol; Michael Weinstein; Michael L Robinson; Gustavo Leone
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

2.  Dual functions of DP1 promote biphasic Wnt-on and Wnt-off states during anteroposterior neural patterning.

Authors:  Wan-Tae Kim; Hyunjoon Kim; Vladimir L Katanaev; Seung Joon Lee; Tohru Ishitani; Boksik Cha; Jin-Kwan Han; Eek-Hoon Jho
Journal:  EMBO J       Date:  2012-07-06       Impact factor: 11.598

3.  ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.

Authors:  Abhishek Datta; Jayita Sen; Jussara Hagen; Chandrashekhar K Korgaonkar; Michael Caffrey; Dawn E Quelle; Douglas E Hughes; Timothy J Ackerson; Robert H Costa; Pradip Raychaudhuri
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 4.  Endoreplication: polyploidy with purpose.

Authors:  Hyun O Lee; Jean M Davidson; Robert J Duronio
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

5.  Visualizing dynamic E2F-mediated repression in vivo.

Authors:  Monica Agromayor; Elzbieta Wloga; Benedetta Naglieri; John Abrashkin; Kapil Verma; Lili Yamasaki
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 6.  Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth.

Authors:  Bruce A Edgar; Norman Zielke; Crisanto Gutierrez
Journal:  Nat Rev Mol Cell Biol       Date:  2014-03       Impact factor: 94.444

7.  E2F/DP Prevents Cell-Cycle Progression in Endocycling Fat Body Cells by Suppressing dATM Expression.

Authors:  Ana Guarner; Robert Morris; Michael Korenjak; Myriam Boukhali; Maria Paula Zappia; Capucine Van Rechem; Johnathan R Whetstine; Sridhar Ramaswamy; Lee Zou; Maxim V Frolov; Wilhelm Haas; Nicholas J Dyson
Journal:  Dev Cell       Date:  2017-12-07       Impact factor: 12.270

8.  Kelch Repeat and BTB Domain Containing Protein 5 (Kbtbd5) Regulates Skeletal Muscle Myogenesis through the E2F1-DP1 Complex.

Authors:  Wuming Gong; Rachel M Gohla; Kathy M Bowlin; Naoko Koyano-Nakagawa; Daniel J Garry; Xiaozhong Shi
Journal:  J Biol Chem       Date:  2015-05-04       Impact factor: 5.157

9.  Cyclins E1 and E2 are required for endoreplication in placental trophoblast giant cells.

Authors:  Tiziana Parisi; Andreas R Beck; Nathalie Rougier; Tom McNeil; Linda Lucian; Zena Werb; Bruno Amati
Journal:  EMBO J       Date:  2003-09-15       Impact factor: 11.598

10.  Critical role of active repression by E2F and Rb proteins in endoreplication during Drosophila development.

Authors:  Li Weng; Chenwen Zhu; Jinhua Xu; Wei Du
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.